Hydrophilic aliphatic polyurethane foams
View Patent ↗The invention relates to hydrophilic, aliphatic polyurethane foams, which are accessible by reacting hydrophilic polyisocyanates in the presence of water. Due to the absorption properties thereof, the polyurethane foams are in particular suited for producing wound dressings, cosmetic articles or incontinence products.
1. A process for preparing hydrophilic aliphatic polyurethane foams wherein compositions comprising
A) hydrophilic polyisocyanates obtainable by reaction of
A1) low molecular weight aliphatic diisocyanates having a molar mass of 140 to 278 g/mol and/or polyisocyanates obtainable therefrom with an isocyanate functionality of 2 to 6, with
A2) monofunctional polyalkylene oxides having an OH number of 10 to 250, and an ethylene oxide content of 50 to 100 mol % based on the total amount of oxyalkylene groups present,
B) heterocyclic 4-ring or 6-ring oligomers of low molecular weight aliphatic diisocyanates having a molar mass of 140 to 278 g/mol,
C) water,
D) optionally catalysts,
E) optionally C 8 to C 22 monocarboxylic acids or their ammonium or alkali metal salts or C 12 to C 44 dicarboxylic acids or their ammonium or alkali metal salts,
F) optionally surfactants,
G) optionally mono- or polyhydric alcohols, and
H) no isocyanate-functional prepolymer having a weight fraction of low molecular weight aliphatic diisocyanates having a molar mass of 140 to 278 g/mol of below 1.0% by weight based on the prepolymer, obtainable by reaction of
H1) low molecular weight aliphatic diisocyanates having a molar mass of 140 to 278 g/mol with
H2) di- to hexafunctional polyalkylene oxides having an OH number of 22.5 to 112 mg KOH/g and an ethylene oxide content of 50 to 100 mol % based on the total amount of oxyalkylene groups present,
are provided, foamed and cured.
2. The process of claim 1 , wherein hydrophilic polyisocyanates A) having an NCO content of 0.3% to 20% by weight are used.
3. The process of claim 1 , wherein exclusively hexamethylene diisocyanate, isophorone diisocyanate or mixtures thereof are used as low molecular weight aliphatic diisocyanates A1).
4. The process of claim 1 , wherein monofunctional polyalkylene oxides A2) having an OH number of 15 to 150 are used.
5. The process of claim 1 , wherein heterocyclic 4-ring oligomers are used as component B).
6. The process of claim 1 , wherein metal salts, amines, amidines and guanidines are used as catalysts D).
7. The process of claim 1 , wherein potassium or sodium salts of C8 to C22 monocarboxylates or C12 to C44 dicarboxylates are used as component E).
8. The process of claim 1 , wherein EO-PO block copolymers are used as surfactants F).
9. The process of claim 1 , wherein ethanol, propanol, butanol, decanol, tridecanol, hexadecanol, ethylene glycol, neopentylglycol, butanediol, hexanediol, decanediol, trimethylolpropane, glycerol, pentaerythritol, monofunctional polyether alcohols and polyester alcohols, polyether diols and polyester diols and also mixtures thereof are used as mono- or polyhydric alcohols G).
10. The process of claim 1 , wherein the components A) to H) are used in the following amounts:
45 to 80 parts by weight of hydrophilic polyisocyanates A)
5 to 50 parts by weight of heterocyclic oligomers B)
1 to 50 parts by weight of water C)
0 to 1 part by weight of catalysts D)
0 to 5 parts by weight of C 8 to C 12 monocarboxylic acids or their ammonium or alkali metal salts or C 12 to C 44 dicarboxylic acids or their ammonium or alkali metal salts E),
0 to 10 parts by weight of surfactants F)
0 to 20 parts by weight of alcohols G).
11. A polyurethane foam obtainable by the process of claim 1 .
12. A wound dressing, cosmetic article, or incontinence product comprising the polyurethane foam of claim 11 .